HEMGENIX

Serial Number 97035438
Registration 7051847
700

Registration Progress

Application Filed
Sep 20, 2021
Under Examination
Approved for Publication
Feb 28, 2023
Published for Opposition
Feb 28, 2023
Registered
May 16, 2023

Trademark Image

HEMGENIX

Basic Information

Serial Number
97035438
Registration Number
7051847
Filing Date
September 20, 2021
Registration Date
May 16, 2023
Published for Opposition
February 28, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
May 16, 2023
Registration
Registered
Classes
005

Rights Holder

CSL Behring L.L.C.

16
Address
1020 First Avenue
King of Prussia, PA 194060901

Ownership History

CSL Behring L.L.C.

Original Applicant
16
King of Prussia, PA

CSL Behring L.L.C.

Owner at Publication
16
King of Prussia, PA

CSL Behring L.L.C.

Original Registrant
16
King of Prussia, PA

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
1200 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230516)
Due Date
May 16, 2029
Grace Period Ends
November 16, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
May 16, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 16, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 28, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 28, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 8, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 20, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 19, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 19, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 19, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jan 6, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 5, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 5, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Dec 30, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Dec 30, 2022 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Dec 30, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Dec 27, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 27, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 27, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 27, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 27, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 27, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 22, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 26, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 23, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 23, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in gene therapy and cell therapy for the treatment of hemophilia

Additional Information

Design Mark
The mark consists of "HEMGENIX" to the right of a helix design.

Classification

International Classes
005